PALMOPLANTAR PUSTULOSIS (PPP)
Clinical trials for PALMOPLANTAR PUSTULOSIS (PPP) explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS (PPP) trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS (PPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for chronic hand and foot skin disease: xeligekimab enters trial
Disease control Recruiting nowThis study tests a new biologic drug, Xeligekimab, in 10 adults with moderate to severe palmoplantar pustulosis (PPP), a chronic skin condition causing painful pustules on hands and feet. The goal is to see if the drug can reduce symptoms and improve quality of life. Participants…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: PHASE4 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New daily pill aims to ease painful hand and foot blisters
Symptom relief Recruiting nowThis study tests a new pill, ivarmacitinib, in 60 adults with palmoplantar pustulosis (PPP), a chronic skin condition causing painful blisters on hands and feet. Participants take one 4mg pill daily for 12 weeks. Researchers will measure how well it reduces symptoms and track sid…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: NA • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated May 26, 2026 10:03 UTC